Top compounds associated with response to OR5H15


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA COL-3 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.03 0.7
mRNA Vorinostat gCSI pan-cancer AAC 0.07 0.7
mRNA VX-680 CTRPv2 pan-cancer AAC 0.041 0.7
mRNA ML162 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV